Dissolving Microneedles: Applications and Growing Therapeutic Potential

    June 2022 in “ Journal of Controlled Release
    Ziad Sartawi, Caroline Blackshields, Waleed Faisal
    From the encyclopedia
    Valproic acid →

    an anticonvulsant repurposed for hair loss via histone inhibition

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Image
    Studysummary This review discusses the advantages, applications, and current trends of dissolving microneedles for drug delivery across various therapeutic areas and reports no new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.
    The review discusses the potential of dissolving microneedles for transdermal delivery of therapeutic compounds. These microneedles have superior drug loading capabilities and can be made entirely from the therapeutic agent. They have applications in various areas including cosmetics, vaccine delivery, diagnosis, cancer, pain and inflammation, diabetes, hair and scalp disorders, and inflammatory skin diseases. In hair and scalp disorders, microneedles containing valproic acid and finasteride have shown promising results in promoting hair growth in mouse models. Despite their potential, challenges such as rapid skin healing, complex manufacturing processes, potential infection risks, limited dosing capacity, and regulatory and commercial barriers need to be addressed. The market for microneedles is expected to grow at a compound annual growth rate of 7.1% through to 2027.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results